AXXE is back on radar….Take notice now!

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

MajorPennyStocks Newsletter

MAJOR WINNER Update Tuesday, July 22nd, 2014 OTC: AXXE ==========

**News Flash: Put AXXE on back on your radar watch list right now….The news the company has put out in July thus far indicates full throttle of implementation towards a well rounded health/fitness/supplemental/pain relief market share.**

AXXE is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas.

AXXE `s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain — to optimal health management through improved nutritional supplements and medicine.

AXXE distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. The company was founded in 1997 and is headquartered in Markham, Canada.

AXXE `s 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more.

AXXE intends to market these products with affordable pricing and widespread availability. According to the corporate website for AXXE, “The company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.” There is so much focus on health care recently. If you really thought about it closely, the switch from a sedentary lifestyle to an active one is optimal. This is why I like AXXE as a company and always enjoy giving updates. AXXE is progressing in some of the top revenue producing markets today: Supplements, pain relief, sports performance.

**Recent Developments**

__Axxess Pharma to Launch High Protein, Fat Burning Ready to Drink (RTD) Protein Meal Replacement Products in Fall of 2014 ▪ ▪ AXXE announced through its wholly-owned subsidiary, AllStar Health Brands Inc., that they will be launching a line high protein, fat burning Ready to Drink (RTD), protein meal replacement products in the fall of 2014. The early launch of these products was fueled by the strong feedback from several large, national US retailers.

▪ ▪ Axxess has been working with its Australian distributor, and formulator, and has developed a suite of high demand, high-quality products.. For years, the Australian and New Zealand dairy herds have been the optimal source for their whey protein and providing the finest protein supplements. These meal replacement/protein drinks have several advantages over the competition. Axxess Pharma believes this will translate into strong residual sales.

_Dr. Bagi, President of Axxess Pharma stated: “The timing is perfect for these new products, especially with the high level of interest shown from our ECRM buyers` meetings of last week. Thanks to the R & D efforts in Australia, we have developed a great tasting product with the added benefit of being able to integrate L-Carnitine into the formula, giving the products a unique combination of high protein intake, with the added benefit of fat-burning even when not working out.”_ _Dr. Bagi, further stated, “This line of meal replacement protein-building products can satisfy both the high-performance athlete as well as persons just wishing to replace a meal with a product that will help them burn fat.”_ **Axxess Pharma Announces Financial Audits and Form S-1 to Be Filed With SEC Within One Week for Fully Reporting Status**

_The completion of audited financials by Axxess Pharma Inc. is one more step in providing added transparency to all of the Company`s shareholders. The filings will be available on the SEC website at such time as they commence filing with the SEC._ _Management is now preparing to file their S-1 Registration Statement with the SEC to become a fully reporting Company and move to the OTC: BB. This listing will allow investors, stock brokers, wealth managers and Portfolio Managers to have improved tradability of the stock._ **Axxess Pharma Inc. Announces US Military (AAFES) Quickly Increasing Rate of Purchase Orders for TapouT Line of Products**

AXXE announced through its wholly owned subsidiary AllStar Health Brands Inc. that they have received their third purchase order from the Army Air Force Exchange Service (AAFES). This is the second purchase order from AAFES within 2 weeks. The latest purchase order is for TapouT`s line of all-natural pain relief products. The first purchase order by AAFES was valued at almost thirty thousand USD.

_Dr. Daniel Bagi, President of Axxess Pharma, stated, “We are honored to quickly receive our third purchase order from the Army Air Force Exchange Service (AAFES). This purchase order is for our all-natural line of pain relief products. This is the second purchase order from AAFES in two weeks. With AAFES having over 2,817 facilities worldwide, we anticipate accelerated global sales from the US military throughout 2014 and 2015.”_ As you look thoroughly over the chart you notice a recent tight range that has AXXE positioned with support at around 22.5 cents and resistance at roughly 27.3 cents. I would imagine the short term trader`s like to play the dips for the quick hits….as the mid to long term players are zeroed in on the 50 cents high that was hit in March of 2014.

We can talk about technicals and fundamentals until blue in the face…..but the one thing that has me warm and fuzzy about AXXE is the company`s consistency of trying to add shareholder value.

With the recent S-1 filings to potentially receive OTCBB status to the sponsorship deals with race cars and a prospective new Ready To Drink Protein shake (RTD) that could hit the marketplace this Fall…….it is evident that we keep all eyes on AXXE right now.

If you were a subscriber here in January, you have seen AXXE go from 18 cents to 50 cents. Now at a quarter, the ball is in your court to recognize the urgency to continue research.

further your research on AXXE at:

I will check back with you with any news or updates.

Speak to you soon, THE MAJOR Editor-in-Charge This report/release/advertisement is a commercial advertisement and is for general information purposes only. **We do not buy or sell and we do not any receive shares in any of our profiled companies.** Please consult with an advisor. This is just a starting point of research and all information was derived from public sources.

The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE WELL: employees are not Registered as an Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. has been compensated the sum total of eighteen thousand dollars by a third party (Ramos & Ramos) for a AXXE advertisement from January 6th, 2014 until July 28th, 2014.. These third parties, may have shares and may liquidate them, which may negatively affect the stock price. affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice which may negatively affect the market. Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise, damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks.. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D,,, and is compliant with the Can Spam Act of 2003. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised herein. Full disclaimer can be read at .

Web Version

This entry was posted in MajorPennyStocks and tagged , , . Bookmark the permalink.

Comments are closed.